Shandong Luoxin Pharmaceutical Group HENGXIN Pharmaceutical Co., Ltd.
-
Founded in:
2011-04-11 -
Country:
China -
Address:
West side of Yanbin Road, Feixian Economic Development Zone -
Tax NO.:
913713255728813685 -
Registered Funds:
50 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ENOXACIN GLUCONATE |
Extract from the above information
More
Extract from the above information |
104142-71-4 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CEFMINOX SODIUM |
Unspecified
More
Unspecified |
92636-39-0 | 29 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefpirome sulfate |
No specific description provided
More
No specific description provided |
98753-19-6 | 40 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefoxitin sodium |
Extract from the above information
More
Extract from the above information |
33564-30-6 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefotaxime sodium |
A broad-spectrum third-generation cephalosporin with a low MIC, very stable to beta-lactamase, widely distributed in body fluids and various organs, with few side effects and good stability. It has strong antibacterial activity against Enterobacteriaceae, and both influenza bacilli and gonococci that produce and do not produce beta-lactamase are highly sensitive to this product. It has stronger antibacterial effects on Escherichia coli, aerogenes, various Proteus species, and influenza bacilli than second-generation cephalosporins. It has stronger activity against gram-positive cocci such as hemolytic streptococci and pneumococci.
More
A broad-spectrum third-generation cephalosporin with a low MIC, very stable to beta-lactamase, widely distributed in body fluids and various organs, with few side effects and good stability. It has strong antibacterial activity against Enterobacteriaceae, and both influenza bacilli and gonococci that produce and do not produce beta-lactamase are highly sensitive to this product. It has stronger antibacterial effects on Escherichia coli, aerogenes, various Proteus species, and influenza bacilli than second-generation cephalosporins. It has stronger activity against gram-positive cocci such as hemolytic streptococci and pneumococci. |
64485-93-4 | 45 |